Guanylin (human) (trifluoroacetate salt) |
A peptide hormone activator of GC-C; expression is reduced by 100- to 1,00… |
1 mg |
33140-1 |
More Info
|
Guanylin (human) (trifluoroacetate salt) |
A peptide hormone activator of GC-C; expression is reduced by 100- to 1,00… |
500 µg |
33140-500 |
More Info
|
Guanylyl Imidodiphosphate (lithium salt) |
A nonhydrolyzable GTP analog that binds to and irreversibly activates G pr… |
1 mg |
16880-1 |
More Info
|
Guanylyl Imidodiphosphate (lithium salt) |
A nonhydrolyzable GTP analog that binds to and irreversibly activates G pr… |
10 mg |
16880-10 |
More Info
|
Guanylyl Imidodiphosphate (lithium salt) |
A nonhydrolyzable GTP analog that binds to and irreversibly activates G pr… |
25 mg |
16880-25 |
More Info
|
Guanylyl Imidodiphosphate (lithium salt) |
A nonhydrolyzable GTP analog that binds to and irreversibly activates G pr… |
5 mg |
16880-5 |
More Info
|
Gusacitinib |
A dual inhibitor of JAKs (IC50s = 46, 4, and 11 nM for JAK1-3, respectivel… |
1 mg |
36554-1 |
More Info
|
Gusacitinib |
A dual inhibitor of JAKs (IC50s = 46, 4, and 11 nM for JAK1-3, respectivel… |
10 mg |
36554-10 |
More Info
|
Gusacitinib |
A dual inhibitor of JAKs (IC50s = 46, 4, and 11 nM for JAK1-3, respectivel… |
25 mg |
36554-25 |
More Info
|
Gusacitinib |
A dual inhibitor of JAKs (IC50s = 46, 4, and 11 nM for JAK1-3, respectivel… |
5 mg |
36554-5 |
More Info
|
Guvacine (hydrochloride) |
An inhibitor of GABA uptake (IC50 = 10 µM; Ki = 14 µM) in rat… |
100 mg |
23361-100 |
More Info
|
Guvacine (hydrochloride) |
An inhibitor of GABA uptake (IC50 = 10 µM; Ki = 14 µM) in rat… |
25 mg |
23361-25 |
More Info
|
Guvacine (hydrochloride) |
An inhibitor of GABA uptake (IC50 = 10 µM; Ki = 14 µM) in rat… |
250 mg |
23361-250 |
More Info
|
Guvacine (hydrochloride) |
An inhibitor of GABA uptake (IC50 = 10 µM; Ki = 14 µM) in rat… |
50 mg |
23361-50 |
More Info
|
Guvacoline (hydrobromide) |
A full agonist of atrial and ileal muscarinic receptors with 15-fold reduc… |
1 mg |
17190-1 |
More Info
|
Guvacoline (hydrobromide) |
A full agonist of atrial and ileal muscarinic receptors with 15-fold reduc… |
10 mg |
17190-10 |
More Info
|
Guvacoline (hydrobromide) |
A full agonist of atrial and ileal muscarinic receptors with 15-fold reduc… |
5 mg |
17190-5 |
More Info
|
GW 0742 |
A selective agonist of PPARδ (EC50 = 1.1 nM); exhibits 1,000-fold se… |
10 mg |
10006798-10 |
More Info
|
GW 0742 |
A selective agonist of PPARδ (EC50 = 1.1 nM); exhibits 1,000-fold se… |
25 mg |
10006798-25 |
More Info
|
GW 0742 |
A selective agonist of PPARδ (EC50 = 1.1 nM); exhibits 1,000-fold se… |
5 mg |
10006798-5 |
More Info
|
GW 0742 |
A selective agonist of PPARδ (EC50 = 1.1 nM); exhibits 1,000-fold se… |
50 mg |
10006798-50 |
More Info
|
GW 1100 |
A selective antagonist of GPR40-mediated Ca2+ elevations in HEK293 cells (… |
10 mg |
10008908-10 |
More Info
|
GW 1100 |
A selective antagonist of GPR40-mediated Ca2+ elevations in HEK293 cells (… |
25 mg |
10008908-25 |
More Info
|
GW 1100 |
A selective antagonist of GPR40-mediated Ca2+ elevations in HEK293 cells (… |
5 mg |
10008908-5 |
More Info
|
GW 1100 |
A selective antagonist of GPR40-mediated Ca2+ elevations in HEK293 cells (… |
50 mg |
10008908-50 |
More Info
|
GW 1929 |
An N-aryl tyrosine activator of PPARγ that binds with a Ki value of… |
1 mg |
13689-1 |
More Info
|
GW 1929 |
An N-aryl tyrosine activator of PPARγ that binds with a Ki value of… |
10 mg |
13689-10 |
More Info
|
GW 1929 |
An N-aryl tyrosine activator of PPARγ that binds with a Ki value of… |
25 mg |
13689-25 |
More Info
|
GW 1929 |
An N-aryl tyrosine activator of PPARγ that binds with a Ki value of… |
5 mg |
13689-5 |
More Info
|
GW 2580 |
A selective inhibitor of cFMS kinase (IC50 = 0.03 µM) that prevents… |
1 mg |
15411-1 |
More Info
|
GW 2580 |
A selective inhibitor of cFMS kinase (IC50 = 0.03 µM) that prevents… |
10 mg |
15411-10 |
More Info
|
GW 2580 |
A selective inhibitor of cFMS kinase (IC50 = 0.03 µM) that prevents… |
25 mg |
15411-25 |
More Info
|
GW 2580 |
A selective inhibitor of cFMS kinase (IC50 = 0.03 µM) that prevents… |
5 mg |
15411-5 |
More Info
|
GW 405833 |
A partial agonist of CB2 receptors (EC50 = 0.65 nM); demonstrates anti-inf… |
1 mg |
20219-1 |
More Info
|
GW 405833 |
A partial agonist of CB2 receptors (EC50 = 0.65 nM); demonstrates anti-inf… |
10 mg |
20219-10 |
More Info
|
GW 405833 |
A partial agonist of CB2 receptors (EC50 = 0.65 nM); demonstrates anti-inf… |
25 mg |
20219-25 |
More Info
|
GW 405833 |
A partial agonist of CB2 receptors (EC50 = 0.65 nM); demonstrates anti-inf… |
5 mg |
20219-5 |
More Info
|
GW 406381 |
A NSAID and COX-2 inhibitor (IC50 = 3 nM); selective for COX-2 over COX-1… |
1 mg |
33895-1 |
More Info
|
GW 406381 |
A NSAID and COX-2 inhibitor (IC50 = 3 nM); selective for COX-2 over COX-1… |
10 mg |
33895-10 |
More Info
|
GW 406381 |
A NSAID and COX-2 inhibitor (IC50 = 3 nM); selective for COX-2 over COX-1… |
25 mg |
33895-25 |
More Info
|
GW 406381 |
A NSAID and COX-2 inhibitor (IC50 = 3 nM); selective for COX-2 over COX-1… |
5 mg |
33895-5 |
More Info
|
GW 4064 |
A selective agonist of FXR (EC50 = 15 nM); displays no activity at other n… |
1 mg |
10006611-1 |
More Info
|
GW 4064 |
A selective agonist of FXR (EC50 = 15 nM); displays no activity at other n… |
10 mg |
10006611-10 |
More Info
|
GW 4064 |
A selective agonist of FXR (EC50 = 15 nM); displays no activity at other n… |
5 mg |
10006611-5 |
More Info
|
GW 441756 |
A potent, selective inhibitor of TrkA (IC50 = 2 nM); used to clarify the r… |
1 mg |
16915-1 |
More Info
|
GW 441756 |
A potent, selective inhibitor of TrkA (IC50 = 2 nM); used to clarify the r… |
10 mg |
16915-10 |
More Info
|
GW 441756 |
A potent, selective inhibitor of TrkA (IC50 = 2 nM); used to clarify the r… |
5 mg |
16915-5 |
More Info
|
GW 501516 |
A PPARδ agonist; binds to PPARδ (IC50 = 1 nM); 100-fold select… |
1 mg |
10004272-1 |
More Info
|
GW 501516 |
A PPARδ agonist; binds to PPARδ (IC50 = 1 nM); 100-fold select… |
10 mg |
10004272-10 |
More Info
|
GW 501516 |
A PPARδ agonist; binds to PPARδ (IC50 = 1 nM); 100-fold select… |
5 mg |
10004272-5 |
More Info
|